COVID-19

The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

There is a promising pipeline of vaccine candidates, but what happens if the frontrunners fail?

Sitting Down With… Elaine O’Hara, Chief Commercial Officer at Sanofi Pasteur.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

When following COVID-19 research, it’s hard to keep your eye on the ball...

How is African pharma coping with the COVID-19 pandemic?

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.